Government reforms will radically change China pharma market

摘要

The Third Plenary meeting of top Communist Party leaders in Beijing last November concluded with a rallying cry for reform that will have systemic consequences for pharma manufacturing and distribution. A policy document released alongside the meeting called for the acceleration of health system reform, particularly of public hospitals, while restructuring pharmaceutical prices and reimbursement procedures.